This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.
The assessments include:
Sales
Product portfolios
Distribution tactics
Technological know-how
New products in R&D
Collaborative arrangements
Business strategies.
Contains 80 pages
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000